We are live on ! Find out more
WP

Waycross Partners Portfolio holdings

AUM $1.05B
1-Year Est. Return 20.92%
This Fund
S&P 500
This Quarter Est. Return
+10.5%
1 Year Est. Return
+20.92%
3 Year Est. Return
+78.91%
5 Year Est. Return
+114.23%
10 Year Est. Return
–
AUM
$461M
AUM Growth
+$117M
Cap. Flow
+$81.3M
Cap. Flow %
17.64%
Top 10 Hldgs %
41.02%
Holding
99
New
12
Increased
35
Reduced
15
Closed
4

Top Buys

Rank Stock Value
1
TGT icon
Target
TGT
+$13.3M
2
HUM icon
Humana
HUM
+$12M
3
TMO icon
Thermo Fisher Scientific
TMO
+$10.7M
4
AAPL icon
Apple
AAPL
+$5.41M
5
MSFT icon
Microsoft
MSFT
+$4.78M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$9.98M
2
ADBE icon
Adobe
ADBE
+$6.4M
3
ELAN icon
Elanco Animal Health
ELAN
+$2.14M
4
CSL icon
Carlisle Companies
CSL
+$1.33M
5
MRVL icon
Marvell Technology
MRVL
+$1.32M

Sector Composition

Rank Sector Weight
1 Technology 26.06%
2 Healthcare 20.03%
3 Consumer Discretionary 15.74%
4 Financials 15%
5 Industrials 8.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLR icon
26
Fluor
FLR
$6.85B
$7.17M 1.55%
242,098
+52,539
+28% +$1.51M
WFC icon
27
Wells Fargo
WFC
$265B
$7.1M 1.54%
166,356
+28,330
+21% +$1.14M
LLY icon
28
Eli Lilly
LLY
$1.05T
$5.56M 1.21%
11,850
-23,806
-67% -$9.98M
USB icon
29
US Bancorp
USB
$98.4B
$5.27M 1.14%
159,452
+33,145
+26% +$1.07M
PYPL icon
30
PayPal
PYPL
$49.9B
$5.14M 1.12%
77,098
+4,661
+6% +$318K
C icon
31
Citigroup
C
$217B
$4.59M 1%
99,646
+21,868
+28% +$1.02M
BA icon
32
Boeing
BA
$169B
$3.96M 0.86%
18,746
– –
DXCM icon
33
DexCom
DXCM
$29.6B
$3.58M 0.78%
27,850
+7,450
+37% +$901K
COR icon
34
Cencora
COR
$59.9B
$3.11M 0.67%
16,150
– –
AMD icon
35
Advanced Micro Devices
AMD
$808B
$2.8M 0.61%
24,600
-4,000
-14% -$416K
LVS icon
36
Las Vegas Sands
LVS
$30.1B
$2.79M 0.6%
48,024
-5,000
-9% -$296K
ORLY icon
37
O'Reilly Automotive
ORLY
$71.3B
$2.73M 0.59%
42,825
– –
DE icon
38
Deere & Co
DE
$161B
$2.58M 0.56%
6,379
– –
ZTS icon
39
Zoetis
ZTS
$32.1B
$2.55M 0.55%
14,800
-31
-0.2% -$5.36K
SLB icon
40
SLB Ltd
SLB
$70.3B
$2.41M 0.52%
49,000
– –
DVN icon
41
Devon Energy
DVN
$50.6B
$2.23M 0.48%
46,100
– –
CMG icon
42
Chipotle Mexican Grill
CMG
$44.2B
$2.14M 0.46%
50,000
– –
UNH icon
43
UnitedHealth
UNH
$387B
$1.92M 0.42%
4,000
– –
BIIB icon
44
Biogen
BIIB
$30.4B
$1.71M 0.37%
6,000
– –
MELI icon
45
Mercado Libre
MELI
$92B
$1.65M 0.36%
1,396
+1,000
+253% +$1.26M
COST icon
46
Costco
COST
$417B
$1.62M 0.35%
3,000
– –
ABT icon
47
Abbott
ABT
$175B
$1.58M 0.34%
14,489
– –
SCHW
48
Charles Schwab
SCHW
$177B
$1.52M 0.33%
+26,800
New +$1.4M
CVS icon
49
CVS Health
CVS
$137B
$1.38M 0.3%
20,000
-75
-0.4% -$5.34K
DIS icon
50
Walt Disney
DIS
$170B
$1.34M 0.29%
15,000
– –
1
2
3 4

Similar funds

RC
Randolph Company Cincinnati, Ohio $1.05B AUM 35.91% 1-Year Est. Return
LPC
Long Pond Capital New York $1.05B AUM 16.49% 1-Year Est. Return
ANBT
American National Bank & Trust Wichita Falls, Texas $1.05B AUM 25.3% 1-Year Est. Return
HWCM
Hudson Way Capital Management Dallas, Texas $1.05B AUM 6.84% 1-Year Est. Return
AA
Apriem Advisors Irvine, California $1.05B AUM 22.09% 1-Year Est. Return
AAIM
Asset Advisors Investment Management Augusta, Georgia $1.05B AUM 12.32% 1-Year Est. Return
CIA
CCM Investment Advisers Columbia, South Carolina $1.04B AUM 40.82% 1-Year Est. Return
TPWA
TRUE Private Wealth Advisors Salem, Oregon $1.05B AUM 19.14% 1-Year Est. Return

Waycross Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Waycross Partners held 99 positions worth $461M, up 34% from $344M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Waycross Partners deployed $81.3M of net new capital in Q2 2023, opening 12 new positions and adding to 35 existing holdings. Its largest new stake was Thermo Fisher Scientific: 19,775 shares worth $10.3M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Eli Lilly, an estimated $9.98M trimmed.

  • Waycross Partners's largest Q2 2023 buy was Thermo Fisher Scientific: 19,775 shares worth $10.3M.
  • Waycross Partners added most to Target in Q2 2023, an estimated $13.3M increase.
  • Waycross Partners's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $9.98M.
  • Waycross Partners fully exited Elanco Animal Health in Q2 2023, selling an estimated $2.14M.
  • Waycross Partners's ten largest holdings make up 41% of its $461M portfolio in Q2 2023.
  • Waycross Partners opened 12 new positions and closed 4 in Q2 2023.
  • Waycross Partners's portfolio value rose 34% quarter-over-quarter to $461M.

Based on Waycross Partners's 13F filing for Q2 2023, filed 26 Jul 2023.